EANM Session II　招待講演4-2

[ES2TK] Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors with ¹⁷⁷Lu-octreotate: a View to a Kill.

^○Lisa Bodei (Chair of EANM Radionuclide Therapy Committee)